4.6 Article

Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells

Journal

IMMUNOLOGY
Volume 139, Issue 3, Pages 366-376

Publisher

WILEY
DOI: 10.1111/imm.12083

Keywords

conventional dendritic cells; immunological synapse; naive T cells; respiratory viruses; T-cell priming; type I interferons

Categories

Funding

  1. Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [3100090, 1070352]
  2. FONDEF [D061008]
  3. Biomedical Research Consortium [CTU06]
  4. Millennium Institute on Immunology and Immunotherapy [P07/088-F]
  5. Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)

Ask authors/readers for more resources

Human metapneumovirus (hMPV) is the second most common cause of acute lower respiratory tract infections in children, causing a significant public health burden worldwide. Given that hMPV can repeatedly infect the host without major antigenic changes, it has been suggested that hMPV may have evolved molecular mechanisms to impair host adaptive immunity and, more specifically, T-cell memory. Recent studies have shown that hMPV can interfere with superantigen-induced T-cell activation by infecting conventional dendritic cells (DCs). Here, we show that hMPV infects mouse DCs in a restricted manner and induces moderate maturation. Nonetheless, hMPV-infected DCs are rendered inefficient at activating naive antigen-specific CD4+ T cells (OT-II), which not only display reduced proliferation, but also show a marked reduction in surface activation markers and interleukin-2 secretion. Decreased T-cell activation was not mediated by interference with DC-T-cell immunological synapse formation as recently described for the human respiratory syncytial virus (hRSV), but rather by soluble factors secreted by hMPV-infected DCs. These data suggest that although hMPV infection is restricted within DCs, it is sufficient to interfere with their capacity to activate naive T cells. Altogether, by interfering with DC function and productive priming of antigen-inexperienced T cells, hMPV could impair the generation of long-term immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Federation of Clinical Immunology Societies Goes South 2021: advanced course on molecular and cellular translational immunology

Benjamin Diethelm-Varela, Antonia Reyes, Yvonne Rosenstein, Jorge Kalil, Marcelo Hill, Guillermo Docena, Ignacio Anegon, Pablo A. Gonzalez, Alexis M. Kalergis

Summary: FOCIS Goes South is a course and workshop organized by FOCIS Centers of Excellence (FCEs) from across Latin America, focusing on advanced immunology, flow cytometry, as well as cutting-edge research in autoimmunity, tolerance, cancer, infectious diseases, and vaccines. The second edition of FOCIS Goes South took place virtually with over 950 registered participants due to the COVID-19 pandemic.

IMMUNOTHERAPY (2022)

Review Biochemistry & Molecular Biology

Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome

Enrique Gonzalez-Madrid, Ma. Andreina Rangel-Ramirez, Maria Jose Mendoza-Leon, Oscar Alvarez-Mardones, Pablo A. Gonzalez, Alexis M. Kalergis, Ma. Cecilia Opazo, Claudia A. Riedel

Summary: This review discusses the relevance of the gestational period for the development of multiple sclerosis (MS) in adulthood, pointing out that thyroid hormone deficiency during pregnancy may increase susceptibility to MS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Microbiology

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern

Barbara M. Schultz, Felipe Melo-Gonzalez, Luisa F. Duarte, Nicolas M. S. Galvez, Gaspar A. Pacheco, Jorge A. Soto, Roslye Berrios-Rojas, Liliana A. Gonzalez, Daniela Moreno-Tapia, Daniela Rivera-Perez, Mariana Rios, Yaneisi Vazquez, Guillermo Hoppe-Elsholz, Catalina A. Andrade-Parra, Omar P. Vallejos, Alejandro Pina-Iturbe, Carolina Iturriaga, Marcela Urzua, Maria S. Navarrete, Alvaro Rojas, Rodrigo Fasce, Jorge Fernandez, Judith Mora, Eugenio Ramirez, Aracelly Gaete-Argel, Monica Acevedo, Fernando Valiente-Echeverria, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, Jose Gonzalez-Aramundiz, Pablo A. Gonzalez, Katia Abarca, Alexis M. Kalergis, Susan M. Bueno

Summary: This study reports the impact of a booster dose of CoronaVac on the immune response against Delta and Omicron variants. Four weeks after the booster dose, there was a significant increase in neutralizing antibodies, and specific T cells reached their peak. Furthermore, the immune response induced by the booster showed activity against Delta and Omicron variants.
Article Multidisciplinary Sciences

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles

Pablo F. Cespedes, Ashwin Jainarayanan, Lola Fernandez-Messina, Salvatore Valvo, David G. Saliba, Elke Kurz, Audun Kvalvaag, Lina Chen, Charity Ganskow, Huw Colin-York, Marco Fritzsche, Yanchun Peng, Tao Dong, Errin Johnson, Jesus A. Siller-Farfan, Omer Dushek, Erdinc Sezgin, Ben Peacock, Alice Law, Dimitri Aubert, Simon Engledow, Moustafa Attar, Svenja Hester, Roman Fischer, Francisco Sanchez-Madrid, Michael L. Dustin

Summary: The authors use bead-supported lipid bilayers as synthetic APCs to show that trans-synaptic vesicles produced by T cells in the immunological synapse carry specialized cargos distinct from constitutive extracellular vesicles to serve as intercellular messengers.

NATURE COMMUNICATIONS (2022)

Review Cell Biology

Interplay between Lipid Metabolism, Lipid Droplets, and DNA Virus Infections

Monica A. Farias, Benjamin Diethelm-Varela, Areli J. Navarro, Alexis M. Kalergis, Pablo A. Gonzalez

Summary: This article reviews and discusses the interplay between neutral lipid metabolism and lipid droplets (LDs) in the replication cycle of different DNA viruses. It highlights the role of LDs in modulating viral infection and identifies potentially new molecular targets for the treatment of viral infections.

CELLS (2022)

Article Immunology

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

Katia Abarca, Carolina Iturriaga, Marcela Urzua, Nicole Le Corre, Augusto Pineda, Carolina Fernandez, Angelica Dominguez, Pablo A. Gonzalez, Susan M. Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela Gonzalez, Paula Guzman, Paula Munoz-Venturelli, Carlos M. Perez, Marcela Potin, Alvaro Rojas, Jose Gonzalez-Aramundiz, Nicolas M. S. Galvez, Francisca Aguirre-Boza, Sofia Aljaro, Luis Federico Batiz, Yessica Campisto, Mariela Cepeda, Aaron Cortes, Sofia Lopez, Maria Loreto Perez, Andrea Schilling, Alexis M. Kalergis

Summary: This study investigated the safety and effectiveness of two different immunization schedules of CoronaVac(R) in healthy adults. The results showed that CoronaVac(R) vaccine is safe and effective in preventing severe cases of COVID-19. There were no significant differences in adverse events between the two schedules, and both schedules provided protection against COVID-19 hospitalization.

VACCINES (2022)

Article Public, Environmental & Occupational Health

Contribution of Two-Dose Vaccination Toward the Reduction of COVID-19 Cases, ICU Hospitalizations and Deaths in Chile Assessed Through Explanatory Generalized Additive Models for Location, Scale, and Shape

Humberto Reyes, Benjamin Diethelm-Varela, Constanza Mendez, Diego Rebolledo-Zelada, Bastian Lillo-Dapremont, Sergio R. Munoz, Susan M. Bueno, Pablo A. Gonzalez, Alexis M. Kalergis

Summary: This study evaluates the impact of Chile's initial two-dose vaccination campaign in reducing adverse epidemiological outcomes due to COVID-19. The results suggest that completing vaccination schedules is crucial for minimizing negative outcomes during the pandemic.

FRONTIERS IN PUBLIC HEALTH (2022)

Article Biology

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

Nicolas M. S. Galvez, Gaspar A. Pacheco, Barbara M. Schultz, Felipe Melo-Gonzalez, Jorge A. Soto, Luisa F. Duarte, Liliana A. Gonzalez, Daniela Rivera-Perez, Mariana Rios, Roslye Berrios, Yaneisi Vazquez, Daniela Moreno-Tapia, Omar P. Vallejos, Catalina A. Andrade, Guillermo Hoppe-Elsholz, Carolina Iturriaga, Marcela Urzua, Maria S. Navarrete, Alvaro Rojas, Rodrigo Fasce, Jorge Fernandez, Judith Mora, Eugenio Ramirez, Aracelly Gaete-Argel, Monica L. Acevedo, Fernando Valiente-Echeverria, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, Jose Gonzalez-Aramundiz, Marina Johnson, David Goldblatt, Pablo A. Gonzalez, Katia Abarca, Susan M. Bueno, Alexis M. Kalergis

Summary: This study found that immunization with CoronaVac in Chilean adults promotes robust cellular and humoral immune responses. The 0-28 schedule induced a stronger humoral immune response than the 0-14 schedule.

ELIFE (2022)

Review Immunology

Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection

Pedro H. Silva, Yaneisi Vazquez, Camilo Campusano, Angello Retamal-Diaz, Margarita K. Lay, Christian A. Munoz, Pablo A. Gonzalez, Alexis M. Kalergis, Susan M. Bueno

Summary: Streptococcus pneumoniae is a major cause of pneumonia in children and the elderly worldwide. While there are currently vaccines available, there is a need for non-capsular-based vaccines to overcome certain limitations.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Review Virology

LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections

Linmar Rodriguez-Guilarte, Mario A. Ramirez, Catalina A. Andrade, Alexis M. Kalergis

Summary: LAG-3 is an inhibitory receptor expressed on immune cells, which regulates T cell activation and effector functions in the immune response. Immunotherapies targeting immune checkpoints, including LAG-3, have shown promise in controlling malignant tumors and chronic viral diseases.

VIRUSES-BASEL (2023)

Review Microbiology

Interplay between lipid metabolism, lipid droplets and RNA virus replication

Monica A. Farias, Benjamin Diethelm-Varela, Alexis M. Kalergis, Pablo A. Gonzalez

Summary: Lipids play crucial roles in the cell as membrane components, signaling molecules, and energy storage sources. Lipid droplets, composed of neutral lipids such as triglycerides and cholesterol esters, are not only cellular energy reserves but also involved in regulating oxidative stress, cellular lipotoxicity, and modulating pathogen infection through immune regulation. Lipid metabolism and lipid droplets play important roles in the replication cycle of RNA viruses, and understanding these processes may reveal new targets for antiviral drugs.

CRITICAL REVIEWS IN MICROBIOLOGY (2023)

Article Hematology

Procoagulant phenotype induced by oxidized high-density lipoprotein associates with acute kidney injury and death

Yolanda Prado, Lorena Perez, Felipe Eltit, Cesar Echeverria, Felipe M. Llancalahuen, Pablo Tapia, Pablo A. Gonzalez, Alexis M. Kalergis, Claudio Cabello-Verrugio, Felipe Simon

Summary: Severe systemic inflammation can lead to oxidative stress, promoting the conversion of high-density lipoprotein (HDL) to oxidized HDL (oxHDL), which interacts with vascular endothelial cells (ECs). OxHDL can acquire procoagulant features and modulate coagulation, which has been linked with organ failure in ICU patients. However, the exact role and underlying molecular mechanism of oxHDL in generating a procoagulant phenotype and causing organ failure and death are still unknown.

THROMBOSIS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Heme Oxygenase-1 Expression in Dendritic Cells Contributes to Protective Immunity against Herpes Simplex Virus Skin Infection

Eduardo I. Tognarelli, Luisa F. Duarte, Monica A. Farias, Felipe A. Cancino, Nicolas Corrales, Francisco J. Ibanez, Claudia A. Riedel, Susan M. Bueno, Alexis M. Kalergis, Pablo A. Gonzalez

Summary: Stimulating HO-1 expression in HSV-infected dendritic cells can promote cell viability and inhibit viral egress. It also promotes the expression of anti-inflammatory molecules and activation of virus-specific CD4(+) T cells. Transferring HSV-infected dendritic cells with induced HO-1 expression can enhance virus-specific T cell activation and improve the outcome of HSV-1 skin infection.

ANTIOXIDANTS (2023)

Article Immunology

Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study

Sebastian Mondaca, Benjamin Walbaum, Nicole Le Corre, Marcela Ferres, Alejandro Valdes, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, Patricia Macanas-Pirard, Patricio Ross, Betzabe Cisternas, Patricia Perez, Olivia Cabrera, Valentina Cerda, Ivana Ormazabal, Aldo Barrera, Maria E. Prado, Maria I. Venegas, Silvia Palma, Richard Broekhuizen, Alexis M. Kalergis, Susan M. Bueno, Manuel A. Espinoza, M. Elvira Balcells, Bruno Nervi

Summary: Cancer patients receiving chemotherapy treatment have a lower immune response to SARS-CoV-2 vaccines. Our study demonstrated that booster vaccines elicit strong humoral and cellular responses among cancer patients receiving chemotherapy, regardless of the type of vaccine used as a priming dose. The homologous vaccine regimen was associated with higher neutralizing antibody positivity and total antibody levels.

VACCINES (2023)

Review Microbiology

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines

Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis

Summary: RSV is a significant cause of morbidity and mortality in young children and older adults. The development of RSV vaccines is guided by epidemiologic and pathophysiological evidence, using various vaccine technologies. Currently, there are 24 vaccines in clinical development, including two licensed vaccines.

PATHOGENS (2023)

No Data Available